The systemic availability of oral glutathione

  title={The systemic availability of oral glutathione},
  author={A. Witschi and S. Reddy and B. Stofer and B. Lauterburg},
  journal={European Journal of Clinical Pharmacology},
  • A. Witschi, S. Reddy, +1 author B. Lauterburg
  • Published 2005
  • Medicine
  • European Journal of Clinical Pharmacology
  • SummaryWhen the plasma glutathione concentration is low, such as in patients with HIV infection, alcoholics, and patients with cirrhosis, increasing the availability of circulating glutathione by oral administration might be of therapeutic benefit.To assess the feasibility of supplementing oral glutathione we have determined the systemic availability of glutathione in 7 healthy volunteers.The basal concentrations of glutathione, cysteine, and glutamate in plasma were 6.2, 8.3, and 54 μmol·l−1… CONTINUE READING
    189 Citations

    Figures and Topics from this paper

    Paper Mentions

    Interventional Clinical Trial
    Excessive free radical formation and depletion of the brain's primary antioxidant, glutathione, are established components of Parkinson's disease (PD) pathophysiology. While there… Expand
    ConditionsParkinson's Disease
    Oral Administration of S-acetyl-glutathione: Impact on the Levels of Glutathione in Plasma and in Erythrocytes of Healthy Volunteers
    • 1
    • Highly Influenced
    • PDF
    Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione.
    • 16
    • PDF
    A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.
    • 37
    • PDF
    Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione
    • 9
    • PDF
    Impact of Supplementary Amino Acids, Micronutrients, and Overall Diet on Glutathione Homeostasis
    • 18
    • PDF
    Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers.
    • 82
    Analysis of glutathione: implication in redox and detoxification.
    • 940


    Bioavailability of dietary glutathione: effect on plasma concentration.
    • 89
    • PDF
    Decreased production of glutathione in patients with cirrhosis
    • 70
    High‐dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine
    • 75
    The level and half‐life of glutathione in human plasma
    • 146